Form 4 for DTIL PRECISION BIOSCIENCES INC
Accepted 2024-05-08 00:00:00 ET · period of report 2024-05-08 · accession 0000950170-24-056140 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-08 | 2024-05-08 | DTIL | Kelly John Alexander | CFO | A - Grant | $12.00 | +8,334 | 31.0K | +37% | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-08 | A | A | 8,334 | $12.00 | 31,014 | D | — | — | (F1) Represents shares purchased through a definitive subscription agreement, pursuant to which the Issuer agreed to issue and sell shares of its common stock in a non-brokered private placement to certain members of its management. |